Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticosteroid-induced osteoporosis

J D Adachi1, W G Bensen, A B Hodsman

  • 1Department of Medicine, St Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada.

Seminars in Arthritis and Rheumatism
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterizing types and circumstances of fractures in the Canadian Multicentre Osteoporosis Study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2025
Same author

Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group.

Archives of osteoporosis·2022
Same author

Incremental costs of fragility fractures: a population-based matched -cohort study from Ontario, Canada.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Fragility of results from randomized controlled trials supporting the guidelines for the treatment of osteoporosis: a retrospective analysis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Exploring changes in bone mass in individuals with a chronic spinal cord injury.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

A scorecard for osteoporosis in Canada and seven Canadian provinces.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same journal

Postoperative complications and outcomes after surgical treatment for tophaceous gout: A systematic review and meta-analysis.

Seminars in arthritis and rheumatism·2026
Same journal

Autoantibody associations in patients with early diffuse cutaneous systemic sclerosis: the prospective registry of early systemic sclerosis.

Seminars in arthritis and rheumatism·2026
Same journal

Effectiveness and safety of primary thromboprophylaxis in antiphospholipid antibody carriers by serological 2023 ACR/EULAR domains.

Seminars in arthritis and rheumatism·2026
Same journal

Clustering-based stratification of fibromyalgia subtypes: A comparative analysis of medicated and non-medicated cohorts from two academic centers.

Seminars in arthritis and rheumatism·2026
Same journal

Imaging techniques for assessing the hand in systemic sclerosis: a systematic review.

Seminars in arthritis and rheumatism·2026
Same journal

Evaluating unsupervised and rule-based phenotyping methods versus administrative code counts for systemic sclerosis identification.

Seminars in arthritis and rheumatism·2026
See all related articles

Corticosteroid-induced osteoporosis affects up to 50% of patients, increasing vertebral fracture risk. Management involves addressing reduced bone formation and increased resorption through various therapies.

Area of Science:

  • Rheumatology
  • Endocrinology
  • Bone Metabolism

Background:

  • Corticosteroid-induced osteoporosis is a significant complication.
  • Up to 50% of patients on corticosteroids are at risk for vertebral fractures.
  • Pathophysiology involves reduced bone formation and increased bone resorption, leading to decreased bone mass.

Purpose of the Study:

  • To review the pathophysiology, clinical features, assessment, and treatment of corticosteroid-induced osteoporosis.
  • To provide a comprehensive overview for rheumatologists and clinicians.

Main Methods:

  • Literature review of existing studies and clinical data.
  • Synthesis of information on bone metabolism and therapeutic interventions.

Main Results:

Related Experiment Videos

  • Identified key pathophysiological mechanisms: reduced bone formation and increased bone resorption.
  • Outlined beneficial preventive strategies: calcium and vitamin D, calcitonin, hormone-replacement therapy, thiazide diuretics.
  • Recommended therapies for established bone loss or fractures: bisphosphonates, fluoride, anabolic steroids.

Conclusions:

  • Corticosteroid-induced osteoporosis requires careful management to prevent fractures.
  • A combination of preventive and therapeutic strategies is essential for patient care.
  • Further research may refine treatment protocols for this condition.